Allianz Asset Management
RVMD icon

Allianz Asset Management’s Revolution Medicines RVMD Stock Holding History

Allianz Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
9,582
+203
+2% +$29.7K ﹤0.01% 1826
2026
Q1 		$912K Sell
9,379
-62,191
-87% -$6.28M ﹤0.01% 1728
2025
Q4 		$5.7M Sell
71,570
-1,907
-3% -$125K 0.01% 1076
2025
Q3 		$3.43M Sell
73,477
-49,068
-40% -$1.92M ﹤0.01% 1275
2025
Q2 		$4.51M Buy
122,545
+18,888
+18% +$726K 0.01% 1157
2025
Q1 		$3.67M Sell
103,657
-3,893
-4% -$158K ﹤0.01% 1243
2024
Q4 		$4.7M Buy
107,550
+17,187
+19% +$867K 0.01% 1077
2024
Q3 		$4.1M Buy
90,363
+62,252
+221% +$2.71M 0.01% 1135
2024
Q2 		$1.09M Buy
28,111
+4,391
+19% +$164K ﹤0.01% 1555
2024
Q1 		$764K Buy
+23,720
New +$703K ﹤0.01% 1496

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Allianz Asset Management's RVMD Position: Q2 2026 in Review

Allianz Asset Management increased its Revolution Medicines (RVMD) stake by 2.2% in Q2 2026, buying an estimated $29.7K and bringing the position to 9,582 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Allianz Asset Management first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.7M in Q4 2025. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Allianz Asset Management held 9,582 shares of Revolution Medicines worth $1.04M as of Q2 2026.
  • Allianz Asset Management bought 203 Revolution Medicines shares in Q2 2026, an estimated $29.7K.
  • Revolution Medicines made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1826 holding.
  • Allianz Asset Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • Allianz Asset Management's Revolution Medicines position peaked at $5.7M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.